Pfizer China president claims China's reforms will enhance market vitality, resource allocation, and innovation competitiveness.

Pfizer China president Jean-Christophe Pointeau asserts that China's reforms will boost market vitality, resource allocation, and innovation competitiveness. The recent third plenary session of the 20th CPC Central Committee marked a new chapter in China's reform and opening-up endeavors, emphasizing building a modern economic system, and stressing high-quality development as key to achieving China's modernization.